FierceBiotech  Mar 31  Comment 
Halozyme dips after pancreatic cancer trial halted for futility nptaylor Fri, 03/31/2017 - 03:30
Motley Fool  Mar 30  Comment 
Shares drop after the company announced that enrollment in a phase 1b/2 trial pancreatic cancer has been halted.
Motley Fool  Mar 2  Comment 
Why small-cap biotech stocks Coherus BioSciences, Halozyme Therapeutics, PTC Therapeutics, Radius Health, and Spark Therapeutics could soar.



Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki